A predictive model for progression of chronic kidney disease to kidney failure
- PMID: 21482743
- DOI: 10.1001/jama.2011.451
A predictive model for progression of chronic kidney disease to kidney failure
Abstract
Context: Chronic kidney disease (CKD) is common. Kidney disease severity can be classified by estimated glomerular filtration rate (GFR) and albuminuria, but more accurate information regarding risk for progression to kidney failure is required for clinical decisions about testing, treatment, and referral.
Objective: To develop and validate predictive models for progression of CKD.
Design, setting, and participants: Development and validation of prediction models using demographic, clinical, and laboratory data from 2 independent Canadian cohorts of patients with CKD stages 3 to 5 (estimated GFR, 10-59 mL/min/1.73 m(2)) who were referred to nephrologists between April 1, 2001, and December 31, 2008. Models were developed using Cox proportional hazards regression methods and evaluated using C statistics and integrated discrimination improvement for discrimination, calibration plots and Akaike Information Criterion for goodness of fit, and net reclassification improvement (NRI) at 1, 3, and 5 years.
Main outcome measure: Kidney failure, defined as need for dialysis or preemptive kidney transplantation.
Results: The development and validation cohorts included 3449 patients (386 with kidney failure [11%]) and 4942 patients (1177 with kidney failure [24%]), respectively. The most accurate model included age, sex, estimated GFR, albuminuria, serum calcium, serum phosphate, serum bicarbonate, and serum albumin (C statistic, 0.917; 95% confidence interval [CI], 0.901-0.933 in the development cohort and 0.841; 95% CI, 0.825-0.857 in the validation cohort). In the validation cohort, this model was more accurate than a simpler model that included age, sex, estimated GFR, and albuminuria (integrated discrimination improvement, 3.2%; 95% CI, 2.4%-4.2%; calibration [Nam and D'Agostino χ(2) statistic, 19 vs 32]; and reclassification for CKD stage 3 [NRI, 8.0%; 95% CI, 2.1%-13.9%] and for CKD stage 4 [NRI, 4.1%; 95% CI, -0.5% to 8.8%]).
Conclusion: A model using routinely obtained laboratory tests can accurately predict progression to kidney failure in patients with CKD stages 3 to 5.
Comment in
-
Supplementing creatinine-based estimates of risk in chronic kidney disease: is it time?JAMA. 2011 Apr 20;305(15):1593-5. doi: 10.1001/jama.2011.502. Epub 2011 Apr 11. JAMA. 2011. PMID: 21482745 No abstract available.
Similar articles
-
Validation of the kidney failure risk equation in European CKD patients.Nephrol Dial Transplant. 2013 Jul;28(7):1773-9. doi: 10.1093/ndt/gft063. Epub 2013 May 3. Nephrol Dial Transplant. 2013. PMID: 23645476 Clinical Trial.
-
A Dynamic Predictive Model for Progression of CKD.Am J Kidney Dis. 2017 Apr;69(4):514-520. doi: 10.1053/j.ajkd.2016.07.030. Epub 2016 Sep 29. Am J Kidney Dis. 2017. PMID: 27693260
-
Clinical prediction models for progression of chronic kidney disease to end-stage kidney failure under pre-dialysis nephrology care: results from the Chronic Kidney Disease Japan Cohort Study.Clin Exp Nephrol. 2019 Feb;23(2):189-198. doi: 10.1007/s10157-018-1621-z. Epub 2018 Aug 1. Clin Exp Nephrol. 2019. PMID: 30069609 Free PMC article.
-
Risk prediction in chronic kidney disease: pitfalls and caveats.Curr Opin Nephrol Hypertens. 2012 Nov;21(6):612-8. doi: 10.1097/MNH.0b013e328359072f. Curr Opin Nephrol Hypertens. 2012. PMID: 23042027 Review.
-
Should eGFR and albuminuria be added to the Framingham risk score? Chronic kidney disease and cardiovascular disease risk prediction.Nephron Clin Pract. 2011;119(2):c171-7; discussion c177-8. doi: 10.1159/000325669. Epub 2011 Jul 28. Nephron Clin Pract. 2011. PMID: 21811078 Review.
Cited by
-
Chronic Kidney Disease Progression-A Challenge.Biomedicines. 2024 Sep 27;12(10):2203. doi: 10.3390/biomedicines12102203. Biomedicines. 2024. PMID: 39457516 Free PMC article. Review.
-
A validation study of the kidney failure risk equation in advanced chronic kidney disease according to disease aetiology with evaluation of discrimination, calibration and clinical utility.BMC Nephrol. 2021 May 24;22(1):194. doi: 10.1186/s12882-021-02402-1. BMC Nephrol. 2021. PMID: 34030639 Free PMC article.
-
Predicting Kidney Failure, Cardiovascular Disease and Death in Advanced CKD Patients.Kidney Int Rep. 2022 Oct 3;7(10):2122-2125. doi: 10.1016/j.ekir.2022.08.009. eCollection 2022 Oct. Kidney Int Rep. 2022. PMID: 36217519 Free PMC article. No abstract available.
-
Cost-effectiveness of chronic kidney disease mass screening test in Japan.Clin Exp Nephrol. 2012 Apr;16(2):279-91. doi: 10.1007/s10157-011-0567-1. Epub 2011 Dec 14. Clin Exp Nephrol. 2012. PMID: 22167460 Free PMC article.
-
Neighborhood socioeconomic status and risk of hospitalization in patients with chronic kidney disease: A chronic renal insufficiency cohort study.Medicine (Baltimore). 2020 Jul 10;99(28):e21028. doi: 10.1097/MD.0000000000021028. Medicine (Baltimore). 2020. PMID: 32664108 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous